LRG Research Team Meets in Cleveland
In early May, the LRG Research Team held a two-day in-person meeting in Cleveland, Ohio, at the Cleveland Clinic, where I conduct my research. Two primary aims of the meeting were to work on [...]
Potential Treatment for Imatinib-Resistant GIST Explored
Dr. Ron DeMatteo GIST specialist surgeon Dr. Ron DeMatteo, along with colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC), has published a new paper in the April issue of Cancer Research with potentially [...]
Device Developed at MIT Helps Determine Targeted Drug Treatment
With precision medicine an accepted paradigm in cancer treatment, finding the right targeted drug treatment for each patient can prove challenging. MIT chemical engineers have designed an implantable device, which is about the size [...]
GIST Cancer Journal Spring Issue Out!
The 5th issue of the GIST Cancer Journal, official journal of the LRG and the first academic journal devoted solely to GIST is now available
Blueprint Medicines Presents Preclinical Data on BLU-285
Blueprint Medicines presented new preclinical data on its drug candidate, BLU-285, and its potential value in treatment-resistant GIST and on novel cancer drug targets at the AACR (American Association for Cancer Research) Annual Meeting [...]
LRG Research Team Member Anette Duensing Receives 2014 GIST Award
The GIST Group Switzerland recently awarded its Science Prize to Dr. Anette Duensing, Assistant Professor of Pathology at the University of Pittsburgh Cancer Institute, and a member of the LRG’s Research Team. GIST Group [...]
GIST Cancer Journal Winter Issue Out!
The Life Raft Group is pleased to announce the release of the fourth issue of The GIST Cancer Journal, the official journal of the Life Raft Group and the first academic journal devoted solely to GIST. [...]
Protein Complex Believed To Be Cancer-Causing Gene
A recent study from MD Anderson provides insight into a protein complex that plays a significant role in cancer.In the study at the University of Texas MD Anderson Cancer center, similarities were drawn between bean [...]
Strategies to rapidly identify and validate new therapies for GIST
By Dr. Anette Duensing, University of Pittsburgh Cancer Institute, and Dr. Maria Debiec-Rychter, KU Leuven, Belgium, LRG Research Team Dr. Maria Debiec-Rychter Dr. Anette Duensing Although most GISTs initially respond well [...]
LRG patient registry: powerful tool for patients, physicians and researchers
The time it takes between the appearance of first symptoms of a rare disease and when the correct diagnosis is given, is often years if not decades instead of days or weeks like it is [...]